Angiogenesis in psoriasis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., & Heldin, C.-H. (1989) · Nature · doi:10.1038/338557a0 · Cited by 711
Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., & Dvorak, H. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1141 · Cited by 685 · cited 1×
“demonstrated increased VEGF mRNA production in lesional psoriatic keratinocytes by in situ hybridisation and reported upregulation of VEGFR-1 (flt-1) and VEGFR-2 (KDR/flk-1) on lesional psoriatic microvasculature [21].”
BackgroundDetmar, M., Brown, L. F., Schön, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P., & Jain, R. K. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00262.x · Cited by 550 · cited 1×
“Further evidence for the role of VEGF-mediated angiogenesis in psoriasis comes from the study of a transgenic mouse model in which overexpression of VEGF by basal keratinocytes resulted in an expanded superficial dermal microvasculature similar to that seen in lesional psoriatic skin [27].”
ResultOverexpression of Transforming Growth Factor α in Psoriatic Epidermis
Elder, J. T., Fisher, G. J., Lindquist, P. B., Bennett, G. L., Pittelkow, M. R., Coffey, R. J., Ellingsworth, L., Derynck, R., & Voorhees, J. J. (1989) · Science · doi:10.1126/science.2916128 · Cited by 527
Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
ETTEHADI, P., GREAVES, M. W., WALLACH, D., ADERKA, D., & CAMP, R. D. R. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06244.x · Cited by 481
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432 · cited 2×
“have recently demonstrated that CyA inhibits angiogenesis induced by VEGF and that this effect is mediated through the inhibition of cyclo-oxygenase (Cox)-2, the transcription of which is activated by VEGF in endothelial cells [34].”
BackgroundAngiogenic activity of enzymes
Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, T., Furukawa, T., Yamada, K., Akiyama, S.-I., & Yamada, Y. (1994) · Nature · doi:10.1038/368198a0 · Cited by 344 · cited 1×
“TP is not secreted and site-directed mutagenesis and antibody studies have proved that the promotion of vessel growth by TP is dependent on the catabolism of TP to thymine and 2-deoxy-D-ribose 1-phosphate [23].”
BackgroundThe Primary Histologic Lesion of Seborrheic Dermatitis and Psoriasis*
Pinkus, H., & Mehregan, A. H. (1966) · Journal of Investigative Dermatology · doi:10.1038/jid.1966.16 · Cited by 267 · cited 1×
“Histological examination of biopsies taken from lesions which are just detectable clinically reveals a normal epidermis but with dilated and abnormally orientated capillaries in the papillary dermis [6].”
BackgroundDetmar, M., Yeo, K.-T., Nagy, J. A., van de Water, L., Brown, L. F., Berse, B., Elicker, B. M., Ledbetter, S., & Dvorak, H. F. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12312542 · Cited by 242
Cited by
Angiogenesis and chronic inflammation: cause or consequence?
Costa, C., Incio, J., & Soares, R. (2007) · Angiogenesis · doi:10.1007/s10456-007-9074-0 · Cited by 504
Angiogenesis drives psoriasis pathogenesis
Heidenreich, R., Röcken, M., & Ghoreschi, K. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00669.x · Cited by 383
Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis
Danese, S., Sans, M., de la Motte, C., Graziani, C., West, G., Phillips, M. H., Pola, R., Rutella, S., Willis, J., Gasbarrini, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.054 · Cited by 374
VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis
Scaldaferri, F., Vetrano, S., Sans, M., Arena, V., Straface, G., Stigliano, E., Repici, A., Sturm, A., Malesci, A., Panes, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.064 · Cited by 340
Vitamin D and the skin: Focus on a complex relationship: A review
Mostafa, W. Z., & Hegazy, R. A. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2014.01.011 · Cited by 282
Dirkx, A. E. M., Egbrink, M. G. A. O., Castermans, K., van der Schaft, D. W. J., Thijssen, V. L. J. L., Dings, R. P. M., Kwee, L., Mayo, K. H., Wagstaff, J., Steege, J. C. A. B., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4493com · Cited by 270
“Angiogenesis inhibition is suggested to be a promising approach for the treatment of diseases with a chronic inflammatory component, such as rheumatoid arthritis and psoriasis (38), in which a concomitant proinflammatory activity is undesirable.”
BackgroundAngiogenesis in Chronic Inflammatory Skin Disorders
Lee, H. J., Hong, Y. J., & Kim, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112035 · Cited by 211
Magnetic and Fluorescent Nanoparticles for Multimodality Imaging
Mulder, W. J., Griffioen, A. W., Strijkers, G. J., Cormode, D. P., Nicolay, K., & Fayad, Z. A. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.307 · Cited by 182
“Many other pathologies, such as atherosclerosis, rheumatoid arthritis, endometriosis and psoriasis, are also associated with inflammation and neovascularization [40,44–46].”
Background
Metadata
- Authors
- Creamer, D., Sullivan, D., Bicknell, R., & Barker, J.
- Venue
- Angiogenesis
- Published
- 2002-12
- Volume
- 5
- Issue
- 4
- Pages
- 231-236
- ISSN
- 0969-6970 (ISSN-L)
- 1573-7209
- OpenAlex
- W1506218223
- Cited by
- 165
- References
- 32
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.